The ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD) plays a crucial role in improving the diagnosis, treatment, prevention, and control of infectious diseases by harnessing the power of molecular and genomic techniques. Committed to pioneer innovation, research, education, and policy development in clinical microbiology in diagnostics, ESGMD aims to:
Quality of MALDI-TOF mass spectra in routine diagnostics: results from an international external quality assessment including 36 laboratories from 12 countries using 47 challenging bacterial strains.
Cuénod A, Aerni M, Bagutti C, Bayraktar C, Boz ES, Carneiro CB 6, Casanova C, Coste AT, Damborg P, van Dam DW, Demirci M, Drevinek P, Dubuis O, Fernandez J, Greub G, Hrabak J, Yiğitler GH, Hurych J, Jensen TG, Jost G, Kampinga GA, Kittl S, Lammens C, Lang C, Lienhard R, Logan J, Maffioli C, Mareković I, Marschal M, Moran-Gilad J,Nolte O, Oberle M, Pedersen M, Pflüger V, Pranghofer S, Reichl J, Rentenaar RJ, Riat AR, Rodríguez-Sánchez B, Schilt C, Schlotterbeck AK, Schrenzel J, Troib S, Willems E, Wootton M, Ziegler D, Egli A. Clincal Microbiology and Infection 2023;29(2):190–199.
The Molecular Detective: Solving the Puzzle of Difficult-to-Diagnose Infections
7 October 2024, 12:00 CET
Concerns about the marked shift from culture to molecular diagnostics in peripheral labs for diagnosing gastrointestinal diseases
20 February 2024
Syndromic diagnostics 3 – gastroenteritis
6 February 2023
Genital infections
6 March 2023
Automation in diagnostic bacteriology
8 May 2023
Molecular diagnostics of bloodstream infection, past, present, and future
5 June 2023
Diagnostic Microbiology: MALDI-TOF, genomics, metagenomics, automation and molecular microbiology, 2nd course
Technical workshop
If you have questions or comments for our study group, we warmly invite you to contact us!
